Research output

  1. Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer

    Research output: Contribution to journal › Article › Academic › peer-review

  2. Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems

    Research output: Contribution to journal › Article › Academic › peer-review

  3. ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy

    Research output: Contribution to journal › Article › Academic › peer-review

View all (12) »

ID: 48208